Nasal Delivery of H5N1 Avian Influenza Vaccine Formulated With GenJet™ or in Vivo-jetPEI® Induces Enhanced Serological, Cellular and Protective Immune Responses
Drug Delivery - United Kingdom
doi 10.1080/10717544.2018.1450909
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Informa UK Limited